HOME >> MEDICINE >> NEWS
Global burden of childhood deafness overlooked

The consequences of childhood hearing impairment are often overlooked, according to a Viewpoint published in this weeks edition of The Lancet.

Dr Bolajoko Olusanya, of the Institute of Child Health, University College London, UK, and Professor Valerie Newton, University of Manchester, UK, reviewed disease control priorities published in a World Bank report "The Global Burden of Disease Study" (GBDS) and subsequent Global Burden of Disease Initiative" (GBDI) which followed it.

Among other things the GBDS report sets out cost-effective interventions for international resource mobilisation and allocation to the developing world.

They found that although the figures in the report included adult-onset hearing impairment, they excluded permanent childhood impairment and all other child-onset hearing impairment in the calculations of the burden, financial and social, of this disability worldwide.

The degrees of hearing impairment and its related consequences range from mild dysfunction in language learning for children with a small (16-25 decibel) loss to complete social isolation for those with a hearing loss of 90db or more.

Of 120 million babies born per year in the developing world, an estimated 718,000 will have permanent bilateral hearing impairment as infants. Failure to detect and effectively manage permanent hearing loss in the first year of life has been associated with substantial and irreversible deficits in speech, linguistic and cognitive development.

GBDS justified the exclusion of childhood-onset hearing impairment on the grounds that it was already accounted for as being caused by congenital conditions, infectious diseases or injuries. But evidence suggests that a substantial portion of children have hearing impairment of unknown causation.

National health systems in many developing countries are too weak to bear the added burden of non-fatal but disabling disorders without extern
'"/>

Contact: Bola Olusanya
b.olusanya@ich.ucl.ac.uk
44-207-813-8107
Lancet
12-Apr-2007


Page: 1 2

Related medicine news :

1. Global warmings threat to New York region and how to avoid severe consequences
2. Global integration package welcome news
3. Global Fund must fund salaries of health workers to deliver HIV, TB and malaria treatments
4. Emory University announces new Global Health Institute
5. Global strategies to improve health in developing countries need truly global discussions
6. Global malaria map key weapon in fight against malaria, scientists say
7. Global Environmental Change and Human Health: New project launched at GEC Conference in Beijing
8. Global warming and your health
9. Global view shows strong link between kidney cancer, sunlight exposure
10. Global study shows all tobacco bad for the heart
11. Mount Sinai Global Health Center receives $1M grant

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Global burden childhood deafness overlooked

(Date:6/19/2013)... 19, 2013 Brightree LLC , ... software solutions for the post-acute care industry, has been ranked ... the Healthcare Informatics 100 (HCI 100) list. This ... the U.S. in terms of revenue during the last fiscal ... rate of 85% annually, and the company has built its ...
(Date:6/19/2013)... Boca Raton, FL (PRWEB) June 19, 2013 ... spoke about the positive changes and growth that has occurred ... his nationwide travel club. , Shuman said, "Travel Services has ... program to heights beyond belief. Membership is up, even ... agents to meet the demands of members." , Having been ...
(Date:6/19/2013)... disease Amyotrophic lateral sclerosis (ALS), also known as Lou ... can be classified into four distinct stages, report pathologists ... of Pennsylvania in the Annals of Neurology . ... tissues shows, for the first time, how the fatal ... the central nervous system to other regions of brain ...
(Date:6/19/2013)... derived from a naturally occurring compound (apocynin), has ... with Parkinson,s Disease symptoms by preventing deficits in ... the May 28, 2013 edition of ... postdoctoral fellow at the Medical College of Wisconsin ... Balaraman Kalyanaraman, Ph.D., Harry R. & Angeline ...
(Date:6/19/2013)... Imprivata ®, a leading global provider ... Imprivata OneSign ® leads the single sign-on (SSO) category ... & Services report . CIOs and other healthcare executives ... performance of its products and the quality of its ... is integral to their long-term healthcare IT strategy. ...
Breaking Medicine News(10 mins):Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 2Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 3Health News:Former Owner Eric Shuman Endorses New Owners and Changes Made in Last Year Since Shuman Sold Travel Services Center at Member Conference 2Health News:Staging system in ALS shows potential tracks of disease progression, Penn study finds 2Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 2Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 3
(Date:6/19/2013)... , June 19, 2013   Life Technologies ... a licensing agreement granting Suzhou Ribo Life Sciences ... siRNA therapeutics in China ... formulate proprietary siRNA molecules in combination with Invivofectamine® ... address human diseases with high unmet medical need ...
(Date:6/19/2013)... , 19. Juni 2013 ... mit der Entwicklung von SCS microRESIST™, ... in der Beschichtung mit Parylene gelungen ... von biokompatiblem Parylene mit antimikrobiellen Eigenschaften ... schädlicher Mikroorganismen auf beschichteten medizinischen Geräten. ...
(Date:6/18/2013)... , June 18, 2013  Intercept Pharmaceuticals, Inc.  ... company focused on the development and commercialization of novel ... announced the pricing of an underwritten public offering of ... offering price of $33.01 per share.  In addition, Intercept ... up to an additional 259,500 shares of common stock. ...
Breaking Medicine Technology:Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4Specialty Coating Systems gibt die Einführung einer neuen antimikrobiellen Parylene-Technologie bekannt 2Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2
Cached News: